2024
Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study
Group T, Scholtens D, LeBlanc E, Vesco K, Amy D, Bays K, Massimino S, Robinson S, Schell K, Walters G, Hillier T, Oshiro C, Cordero S, Howick C, Kim L, Martinez Y, Pishchalenko O, Wastlova V, Zork N, Mourad M, Lonier J, Reddy U, Acevedo J, Castillo J, Gomez M, Peguero B, Facco F, Feghali M, Bocan H, Stramowski S, Powe C, Edlow A, Barth W, Nathan D, Azevedo R, Baez A, Iroajanma C, Larkin M, Maya J, Michalopoulos C, Neamonitaki N, Thangthaeng N, Yee L, Lowe W, Grobman W, Szmuilowicz E, Aguirre A, Guevara E, Mallett G, Matos S, Tyagi S, Spadola A, Catalano P, Azimirad A, Werner E, Rouse D, Malloy M, Parra F, Sherr J, Merriam A, Bitterman S, Considine E, Leventhal J, Perley L, Rink L, Steffen A, Thompson B, Zgorski M, Steffes M, Arends V, Killeen A, Siddique J, Bustamante P, Cheung Y, Freeze C, Grott T, Kuang A, Tull M, Linder B. Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study. BMJ Open 2024, 14: e084216. PMID: 38851233, PMCID: PMC11163666, DOI: 10.1136/bmjopen-2024-084216.Peer-Reviewed Original ResearchConceptsLarge-for-gestational-age birth weightMetabolic outcomesLarge-for-gestational-ageDiagnosis of gestational diabetesOral glucose tolerance testAdverse pregnancy outcomesVanderbilt University Institutional Review BoardCourse of pregnancyObservational cohort studyGlucose tolerance testNational Institute of DiabetesDigestive and Kidney DiseasesGDM treatmentWeeks gestationDetect such abnormalitiesPerinatal outcomesGDM screeningInstitutional review boardGestational diabetesFirst-trimesterPregnancy outcomesEarly pregnancyGlucose abnormalitiesBirth weightPregnant adults
2020
VP23.04: Maternal infection and adverse pregnancy outcomes among pregnant travellers: results of the international Zika virus in pregnancy registry
Vouga M, Pomar L, Soriano‐Arandes A, Rodo C, Goncé A, Merriam A, Eperon I, De Tejada B, Eggel B, Masmejan S, Rochat L, Genton B, Lambert V, Malvy D, van Mieghem T, Gérardin P, Baud D, Panchaud A. VP23.04: Maternal infection and adverse pregnancy outcomes among pregnant travellers: results of the international Zika virus in pregnancy registry. Ultrasound In Obstetrics And Gynecology 2020, 56: 156-156. DOI: 10.1002/uog.22695.Peer-Reviewed Original ResearchCan Recurrent Pregnancy Loss Be Prevented by Antithrombotic Agents?
Merriam A, Paidas M. Can Recurrent Pregnancy Loss Be Prevented by Antithrombotic Agents? 2020, 223-230. DOI: 10.1201/9780429450303-24.ChaptersRecurrent pregnancy lossPregnancy outcomesAntiplatelet agentsPregnancy lossAntithrombotic agentsMultiple adverse pregnancy outcomesSmall case-control studyAntiplatelet agent aspirinAdverse pregnancy outcomesSuccessful pregnancy outcomeCase-control studyMultiple prospective studiesHistory of thrombophiliaClass of drugsEffects of anticoagulantsAspirin treatmentProspective studyAnticoagulant agentsLive birthsThrombophiliaBlood clotsWomenAspirinOutcomesAgents
2017
Inflammatory Mediators during the Pre‐implantation Period Play a Key Role in the Pathogenesis of Preeclampsia in the Spontaneous Preeclamptic‐like BPH/5 Mouse
Sones J, Merriam A, Grenier J, Douglas N, Davisson R. Inflammatory Mediators during the Pre‐implantation Period Play a Key Role in the Pathogenesis of Preeclampsia in the Spontaneous Preeclamptic‐like BPH/5 Mouse. The FASEB Journal 2017, 31 DOI: 10.1096/fasebj.31.1_supplement.1033.9.Peer-Reviewed Original ResearchLate gestational hypertensionFetal growth restrictionBPH/5 miceMaternal syndromeC3 gene expressionPregnancy outcomesPreeclamptic pregnanciesDecidual inflammationGrowth restrictionFetal adverse pregnancy outcomesFetal morbidity/mortalityImplantation sitesBPH/5 mouse modelPregnancy time pointsAdverse pregnancy outcomesPoor pregnancy outcomesTime pointsSeverity of preeclampsiaAnti-inflammatory therapyMorbidity/mortalityDevelopment of preeclampsiaPathogenesis of preeclampsiaInnate immune systemPre-implantation periodInflammatory response genes